Incidence of cardiovascular events in patients with atrial fibrillation anticoagulated with rivaroxaban after 2.5 years of follow-up: not all is stroke or bleeding

27 August 2021 (08:00 - 20:00)
Organised by:
Congress Presentation Part of: Atrial fibrillation e-posters Stroke Prevention ESC Premium Access ESC Congress 2021 - The Digital Experience